Company Overview of Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. develops and markets pharmaceuticals. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and other aspects. It serves customers in the United States and internationally. Daiichi Sankyo, Inc. was formerly known as Sankyo Pharma Inc. and changed its name to Daiichi Sankyo, Inc. in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey. Daiichi Sankyo, Inc. operates as a subsidiary of Daiichi Sankyo Company, Limited.
Two Hilton Court
Parsippany, NJ 07054
Founded in 1996
Key Executives for Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Key Developments
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
August 7, 2017
April 3, 2017
|Daiichi Sankyo, Inc., Pharmaceutical Packaging Facility in Bethlehem, Pennsylvania|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Daiichi Sankyo, Inc., please visit dsi.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.